Isoniazid/pyrazinamide/rifampicinHepatitis: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1818卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82438-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：158 / 158

相关论文

共 50 条

[1] Isoniazid/pyrazinamide/rifampicinHepatitis and peripheral neuropathy: 2 case reports
Reactions Weekly, 2023, 1953 (1) : 228 - 228
[2] Isoniazid/pyrazinamide/rifampicinHepatitis A: case report
Reactions Weekly, 2019, 1742 (1) : 136 - 136
[3] Isoniazid/pyrazinamide/rifampicinHepatitis: case report
Reactions Weekly, 2011, 1368 (1) : 25 - 25
[4] Pyrazinamide/rifampicinHepatitis: case report
Reactions Weekly, 2005, 1050 (1) : 16 - 16
[5] Isoniazid/rifampicinHepatitis and aspartate aminotransferase elevation: 2 case reports
Reactions Weekly, 2018, 1687 (1) : 125 - 125
[6] Isoniazid/rifampicinHepatitis: case report
Reactions Weekly, 2020, 1795 (1) : 169 - 169
[7] Isoniazid/pyrazinamide/rifampicinLiver injury: 10 case reports
Reactions Weekly, 2019, 1783 (1) : 151 - 151
[8] Isoniazid/pyrazinamide/rifampicinToxic hepatitis: 17 case reports
Reactions Weekly, 2020, 1827 (1) : 190 - 190
[9] Isoniazid/pyrazinamide/rifampicinVarious toxicities: 2 case reports
Reactions Weekly, 2022, 1921 (1) : 162 - 162
[10] Isoniazid/piperine/rifampicinHepatitis: case report
Reactions Weekly, 2018, 1724 (1) : 220 - 220

← 1 2 3 4 5 →